Name | 7-(diethylamino)-3-(5-methyl-1,3-benzoxazol-2-yl)chromen-2-one |
---|---|
Synonyms |
EINECS 252-093-4
disperse yellow 184 |
Description | EMI48, the derivative of EMI1, displays greater potency toward mutant EGFR than EMI1. EMI48 inhibits EGFR triple mutants[1]. |
---|---|
Related Catalog | |
Target |
EGFRL858R/T790M/C797S EGFRdel19 T790M C797S |
In Vitro | EMI48 inhibits EGFR ex19del/T790M/C797S and EGFR L858R/T790M/C797S. EMI48 can be used in the research of mutant EGFR-associated, drug-resistant non-small-cell lung cancer (NSCLC)[1]. |
References |
Molecular Formula | C21H20N2O3 |
---|---|
Molecular Weight | 348.39500 |
Exact Mass | 348.14700 |
PSA | 59.48000 |
LogP | 4.75580 |
~87% 34564-13-1 |
Literature: Nourmohammadian, Farahnaz; Gholami, Mahnaz Davoodzadeh Synthetic Communications, 2010 , vol. 40, # 6 p. 901 - 909 |
~66% 34564-13-1 |
Literature: Nourmohammadian, Farahnaz; Gholami, Mahnaz Davoodzadeh Synthetic Communications, 2010 , vol. 40, # 6 p. 901 - 909 |
Precursor 4 | |
---|---|
DownStream 0 |